BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aragen Bioscience, Inc. Announces Offering of GLP Services


6/23/2011 3:39:51 PM

(Morgan Hill, CA; June 23, 2011)—Aragen Bioscience, Inc., a preclinical contract research and development organization located in the San Francisco Bay Area, recently announced the offering of in vivo services in compliance with GLP regulations. Previously, the company provided only non-GLP services focused on early stage research and discovery.

“With the implementation of GLP services in our rodent facility, we can now offer our clients a seamless transition from early stage research studies into the GLP compliant studies necessary to support IND submissions to the FDA,” commented Aragen’s President and CEO, Rick Srigley.

Aragen’s in vitro services continue be performed under non-GLP conditions, but Aragen intends to expand its services to include GLP compliant cell-based assays in the near future.

About Aragen Bioscience

Aragen Bioscience, Inc., is a research and development services company located in the San Francisco Bay area. Aragen Bioscience specializes in recombinant cell line and hybridoma development, cell culture and protein purification process development and production, primary and immortalized cell-based assays, in vivo models of human disease and custom immunological services. For more information, visit www.aragenbio.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES